Verdun
Canada
17
2011-07-21
14
2013-11-05
These are the the leading inventors for applications assigned to AEGERA THERAPEUTICS, INC.:
AEGERA THERAPEUTICS, INC. based in Verdun, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
IAP BIR DOMAIN BINDING COMPOUNDS
#2 | 2010-11-18 ✅ Patent 8,575,113 granted on 2013-11-05BIR domain binding compounds
#3 | 2009-02-12IMIDAZO [2,1,-b]-1,3,4-THIADIAZOLE SULFONAMIDES
#4 | 2008-03-20 ✅ Patent 7,579,320 granted on 2009-08-25IAP BIR domain binding compounds
#5 | 2008-01-24 ✅ Patent 7,858,309 granted on 2010-12-28Method for differentiating between multiple sclerosis subtypes
#6 | 2008-01-17 ✅ Patent 7,547,724 granted on 2009-06-16IAP BIR domain binding compounds
#7 | 2007-11-15 ✅ Patent 7,714,003 granted on 2010-05-11Imidazo[2,1-]-1,3,4-thiadiazole sulfonamides
#8 | 2007-09-20 ✅ Patent 8,063,095 granted on 2011-11-22IAP BIR domain binding compounds
#9 | 2007-09-20 ✅ Patent 8,021,840 granted on 2011-09-20Diagnostic marker for interferon responsiveness in multiple sclerosis
#10 | 2007-04-26 ✅ Patent 7,795,298 granted on 2010-09-14IAP BIR domain binding compounds
#11 | 2007-04-26 ✅ Patent 7,589,118 granted on 2009-09-15IAP BIR domain binding compounds
#12 | 2006-10-31 ✅ Patent 7,129,250 granted on 2006-10-31Neuroprotective and anti-proliferative compounds
#13 | 2006-08-15 ✅ Patent 7,091,333 granted on 2006-08-15Antisense IAP nucleobase oligomers and uses thereof
#14 | 2006-08-08 ✅ Patent 7,087,584 granted on 2006-08-08Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease
#15 | 2006-06-27 ✅ Patent 7,067,281 granted on 2006-06-27Mammalian IAP gene family, primers, probes and detection methods
#16 | 2006-02-23XAF genes and polypeptides: methods and reagents for modulating apoptosis
#17 | 2005-03-31 ✅ Patent 7,230,019 granted on 2007-06-12Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamides
214880 ⎘